On August 11th Topcon Corporation of Tokyo announced the signing of an agreement to purchase the glaucoma and retina related assets of OptiMedica Inc (Santa Clara, California). The purchase follows on from a successful distribution partnership between the two companies for OptiMedica’s proprietary PASCAL (PAttern SCAn Laser) photocoagulation system. Commenting on the deal Hiroshi Fukuzawa of Topcon stated that demographics and continued increase in the incidence of diabetic and age-related eye disease ensures that “the therapeutic laser market continues to be a major opportunity in ophthalmology”.